Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5676
Ascent Industries
ACNT
$137M
| $87K | ﹤0.01% |
5,534
+2,797
| +102% | +$48.2K |
|
5677
Aldeyra Therapeutics
ALDX
$91.7M
| $87K | ﹤0.01% |
14,541
+6,342
| +77% | +$47.7K |
|
5678
Alphatec Holdings
ATEC
$1.55B
| $87K | ﹤0.01% |
+19,241
| New | +$71.8K |
|
5679
Fastly Inc
FSLY
$3.63B
| $87K | ﹤0.01% |
+4,319
| New | +$89K |
|
5680
CALL
GATX Corp
GATX
$6.43B
| $87K | ﹤0.01% |
1,100
+100
| +10% | +$7.6K |
|
5681
GSI Technology
GSIT
$227M
| $87K | ﹤0.01% |
10,192
-81,025
| -89% | -$652K |
|
5682
LiveOne
LVO
$61.5M
| $87K | ﹤0.01% |
2,105
+999
| +90% | +$44.1K |
|
|
OTRK
5683
DELISTED
Ontrak
OTRK
| $87K | ﹤0.01% |
51
-241
| -83% | -$361K |
|
5684
PUT
Smith & Wesson
SWBI
$655M
| $87K | ﹤0.01% |
12,620
+6,635
| +111% | +$47K |
|
|
FLG
5685
PUT
Flagstar Bank National Association
FLG
$5.94B
| $87K | ﹤0.01% |
2,900
+600
| +26% | +$19.4K |
|
|
ORTX
5686
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $87K | ﹤0.01% |
617
+605
| +5,042% | +$106K |
|
|
PYX
5687
DELISTED
Pyxus International, Inc.
PYX
| $87K | ﹤0.01% |
5,663
-18,453
| -77% | -$348K |
|
5688
CALL
ProShares UltraShort Euro
EUO
$34.9M
| $86K | ﹤0.01% |
3,400
+2,900
| +580% | +$74.8K |
|
5689
Galectin Therapeutics
GALT
$200M
| $86K | ﹤0.01% |
20,788
-111,603
| -84% | -$483K |
|
5690
PUT
ProShares UltraShort Gold
GLL
$125M
| $86K | ﹤0.01% |
+350
| New | +$99.7K |
|
5691
Genco Shipping & Trading
GNK
$1.15B
| $86K | ﹤0.01% |
10,094
+6,956
| +222% | +$57.5K |
|
|
HAPN
5692
CALL
Happen Inc
HAPN
$2.36B
| $86K | ﹤0.01% |
6,920
-1,560
| -18% | -$24.6K |
|
5693
Shinhan Financial Group
SHG
$33.4B
| $86K | ﹤0.01% |
2,213
+297
| +16% | +$11.5K |
|
5694
PUT
Zumiez
ZUMZ
$341M
| $86K | ﹤0.01% |
3,300
-2,800
| -46% | -$68K |
|
5695
Zymeworks
ZYME
$1.61B
| $86K | ﹤0.01% |
+3,900
| New | +$71.6K |
|
|
OTIC
5696
DELISTED
Otonomy, Inc.
OTIC
| $86K | ﹤0.01% |
31,259
-93
| -0.3% | -$248 |
|
|
LEVL
5697
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $86K | ﹤0.01% |
3,424
+1,778
| +108% | +$42.7K |
|
5698
Ardelyx
ARDX
$1.23B
| $85K | ﹤0.01% |
31,492
+17,998
| +133% | +$54.2K |
|
|
BPT
5699
CALL
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $85K | ﹤0.01% |
5,500
-8,200
| -60% | -$161K |
|
5700
Flexsteel Industries
FLXS
$307M
| $85K | ﹤0.01% |
4,972
+2,663
| +115% | +$54.6K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.